NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

Efgartigimod Meets End Point in Seronegative Myasthenia Gravis Study, Cemdisiran Submission for MG Coming Soon, Phase 3 Studies of IncobotulinumtoxinA Begin

Published: August 30th 2025 | Updated: August 30th 2025

Neurology News Network. for the week ending August 30, 2025. [WATCH TIME: 4 minutes]

Vatiquinone Recieves CRL, RAINBOWFISH Study Published in NEJM, Hearing Aids Show Protective Effects Against Dementia

NeurologyLive® Staff

Published: August 23rd 2025 | Updated: August 23rd 2025

Neurology News Network. for the week ending August 23, 2025. [WATCH TIME: 4 minutes]

Vormatrigine Reduces Seizures in Phase 2 RADIANT Study, Postpartum Depression in MS Women, Ianalumab Produces Significant Phase 3 Data in Sjögren’s disease

NeurologyLive® Staff

Published: August 16th 2025 | Updated: August 16th 2025

Neurology News Network. for the week ending August 16, 2025. [WATCH TIME: 4 minutes]

Elecsys Blood Test Gains EU Approval, FDA Expands Fremanezumab Indication Into Pediatrics, VX-993 Fails Phase 2 Pain Trial

NeurologyLive® Staff

Published: August 9th 2025 | Updated: August 2nd 2025

Neurology News Network. for the week ending August 9, 2025. [WATCH TIME: 4 minutes]

IHL-42X Performs in Phase 2 RePOSA Study, ATH434 Eyes Phase 3 Multiple System Atrophy Trial, 4-Year Data on Lecanemab Unveiled

NeurologyLive® Staff

Published: August 2nd 2025 | Updated: August 2nd 2025

Neurology News Network. for the week ending August 2, 2025. [WATCH TIME: 4 minutes]

This Week on NeurologyLive® — July 28, 2025

NeurologyLive® Staff

July 28th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Gefurulimab Positive Phase 3 Data Released, PoNS Device Eyes Stroke Indication, AD109 Performs in Phase 3 LunAIRo Trial

NeurologyLive® Staff

Published: July 26th 2025 | Updated: July 26th 2025

Neurology News Network. for the week ending July 26, 2025. [WATCH TIME: 4 minutes]

This Week on NeurologyLive® — July 21, 2025

NeurologyLive® Staff

July 21st 2025

Here's some of what is coming soon to NeurologyLive® this week.

Sleep Agent Oveporexton Meets End Points in Phase 3 Studies, XPro Shows Mixed Phase 2 Data, Ultraprocessed Food Consumption Linked to Parkinson's Features

NeurologyLive® Staff

Published: July 19th 2025 | Updated: July 19th 2025

Neurology News Network. for the week ending July 19, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — July 18, 2025

NeurologyLive® Staff

July 18th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 18, 2025.

This Week on NeurologyLive® — July 14, 2025

NeurologyLive® Staff

July 14th 2025

Here's some of what is coming soon to NeurologyLive® this week.

FDA Approves Updated Donanemab Labeling, BLA Accepted for Tividenofusp Alfa, Nipocalimab Outperforms FcRn Blockers

NeurologyLive® Staff

Published: July 12th 2025 | Updated: July 12th 2025

Neurology News Network. for the week ending July 12, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — July 11, 2025

NeurologyLive® Staff

July 11th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 11, 2025.

This Week on NeurologyLive® — July 7, 2025

NeurologyLive® Staff

July 7th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Salanersen Shows Promise in Phase 1, MESA Open-Label Data Released, Fenfluramine Meets End Points in Phase 3 GEMZ Trial

NeurologyLive® Staff

Published: July 5th 2025 | Updated: July 5th 2025

Neurology News Network. for the week ending July 5, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — July 4, 2025

NeurologyLive® Staff

July 4th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 4, 2025.

This Week on NeurologyLive® — June 30, 2025

NeurologyLive® Staff

June 30th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Eptinezumab Improves Medication Overuse Headache, Submission for GTx-104 in Subarachnoid Hemorrhage, FDA Expands Indication for Vizamyl PET Imaging

NeurologyLive® Staff

Published: June 28th 2025 | Updated: June 28th 2025

Neurology News Network. for the week ending June 28, 2025. [WATCH TIME: 4 minutes]

This Week on NeurologyLive® — June 23, 2025

NeurologyLive® Staff

June 23rd 2025

Here's some of what is coming soon to NeurologyLive® this week.

Atogepant Outperforms Topiramate, IND Accepted for ORX142, Prasinezumab Heads to Phase 3 Parkinson Disease Studies

NeurologyLive® Staff

Published: June 21st 2025 | Updated: June 21st 2025

Neurology News Network. for the week ending June 21, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 20, 2025

NeurologyLive® Staff

June 20th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 20, 2025.

Understanding How a Rare Brain Wasting Disease Hides in Neurons For Decades

NeurologyLive® Staff

June 16th 2025

Researchers uncover a latent infection model for Creutzfeldt-Jakob disease, revealing insights into its mysterious origins and potential triggers.

This Week on NeurologyLive® — June 16, 2025

NeurologyLive® Staff

June 16th 2025

Here's some of what is coming soon to NeurologyLive® this week.

Once-Nightly Oxybate Reduces Sleep-Related Eating, Samelisant Improves Excessive Daytime Sleepiness, Tirzepatide's Impact on OSA and Obesity

NeurologyLive® Staff

Published: June 14th 2025 | Updated: June 14th 2025

Neurology News Network. for the week ending June 14, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 13, 2025

NeurologyLive® Staff

June 13th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 13, 2025.

This Week on NeurologyLive® — June 9, 2025

NeurologyLive® Staff

June 9th 2025

Here's some of what is coming soon to NeurologyLive® this week.

RGX-202 Shows Continued Promise in DMD, AJ201 Meets End Points in Spinal and Bulbar Muscular Atrophy, Ponesimod Effect Sustained Over Long-Term

NeurologyLive® Staff

Published: June 7th 2025 | Updated: June 7th 2025

Neurology News Network. for the week ending June 7, 2025. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — June 6, 2025

NeurologyLive® Staff

June 6th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 6, 2025.

This Week on NeurologyLive® — June 2, 2025

NeurologyLive® Staff

June 2nd 2025

Here's some of what is coming soon to NeurologyLive® this week.

ADDRESS-LC Study of Long COVID Initiated, Phase 4 Trial Testing IVIg Transition to Efgartigimod, Lack of Rebound Effect Seen in Ozanimod

NeurologyLive® Staff

Published: May 31st 2025 | Updated: May 31st 2025

Neurology News Network. for the week ending May 31, 2025. [WATCH TIME: 4 minutes]

1 2 3 4 5 6 7 8

...

37 >

Latest Updated Articles

Anna Burke, MD (Credit: Barrow Neurological Institute)

Published: July 28th 2025 | Updated: July 30th 2025

Indirect Comparison Study Hints at Lower ARIA and ICH-Related Mortality Risk in Lecanemab Over Donanemab

Jannis Müller, MD, MSc (Credit: LinkedIn)

Published: May 14th 2025 | Updated: May 16th 2025

Observed Differences in PIRA Definition Call for More Standardized Agreement on Term

Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)

Published: May 12th 2025 | Updated: May 13th 2025

Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity

Published: March 27th 2025 | Updated: March 28th 2025

FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome

Published: March 4th 2025 | Updated: March 19th 2025

BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts

Published: January 30th 2025 | Updated: February 21st 2025

FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management

Do Not Sell My Information

Terms and Conditions

Privacy

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777